OLPAOffice of Legislative Policy and Analysis
FAQs | Site Map | Links | Home
November 29, 2015
skip navigation

  (spacer) Bill Tracking

  (spacer) Legislative Updates

  arrow Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH

  (spacer) OLPA

margin frame

Congressional ActionsPublic Laws

109th Congress

arrow indicating current page Session I | Session II

P.L. 109-129 - The Stem Cell Therapeutic and Research Act of 2005

On December 20, 2005, the President signed H.R. 2520, the Stem Cell Therapeutic and Research Act of 2005, as Public Law 109-129. The bill does not have a direct impact on NIH. It would require the Secretary of HHS, acting through the Director of HRSA, to establish the C.W. Bill Young Cell Transplantation Program, a network of cord blood banks to facilitate the use of cord blood for transplantation purposes. Cord blood units that are collected, but not appropriate for clinical use, would be required to be made available for peer-reviewed research.



Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy